Month: November 2021

Revelation Biosciences Inc. Announces Initiation of a Phase 1b Clinical Study of REVTx-99 for the Experimental Treatment of Allergic Rhinitis and Chronic Nasal Congestion

-Top-line data anticipated in the first quarter of 2022-SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (Revelation),...

Kala Pharmaceuticals Acquires Combangio, Expanding its Pipeline with a Clinical-Stage Novel Biologic for the Treatment of Persistent Corneal Epithelial Defect (PCED) and other Rare Ocular Surface Diseases

Abdul Latif Jameel Health and Butterfly Network enter strategic distribution partnership to bring Butterfly iQ+ ultrasound device to a potential 2 billion1 people across the Middle East, North Africa, Turkey & India

error: Content is protected !!